TerminatedPhase 2Phase 3

Open Label Safety & Pharmacodynamic Study 24Wk w/DIO-902 Combo w/Metformin & Atorvastatin in T2DM Patients

NCT00622089

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

Dr. Terence Hart

Muscle Shoals, Alabama, United States

+23 additional locations

Save this trial

Dr. Terence HartMuscle Shoals, Alabama, United States
Genova ResearchTucson, Arizona, United States
Research SolutionsJonesboro, Arkansas, United States
Arkansas Primary Care ClinicLittle Rock, Arkansas, United States
Advanced Medical ResearchLakewood, California, United States
Mills-Peninsula Helath ServicesSan Mateo, California, United States
Diabetes Research Goup University of Hawaii at ManoaHonolulu, Hawaii, United States
Creighton Diabetes CenterOmaha, Nebraska, United States
AHS Oklahoma Physician GroupTulsa, Oklahoma, United States
Covance Clinical Research Unit - Dr. Andrew AhmannPortland, Oregon, United States
Covance CRUAustin, Texas, United States
Diabetes Glandular Disease Research AssociatesSan Antonio, Texas, United States
Flinders Medical CentreAdelaide, South Australia, Australia
Lyell McEwin HospitalNorth Western Adelaide, South Australia, Australia
ECRUBox Hill, Melbourne, Victoria, Australia
School of Medicine and PharmacologyFremantle, Western Australia, Australia
Keough InstituteNedands, Western Australia, Australia
Endocrinology Research UnitHerston Road, Australia
Endocrinology DepartmentSt Leonards, Australia
Royal Melbourn HospitalVictoria, Australia
Middlemore HospitalOtahuhu, Auckland, New Zealand
Lipid and Diabetes ResearchChristchurch, New Zealand
Waikaito HospitalHamilton, New Zealand
Diabetes CentreWellington, New Zealand